Suivez-nous
FR
FR
FR

L'un des principaux objectifs de Life4me + - est de prévenir de nouveaux cas de VIH et d'autres IST, d'hépatite C et de tuberculose.

L'application aide à établir une communication anonyme entre les médecins et les personnes séropositives. Elle vous permet d'organiser facilement votre horaire de prise de médicaments et de définir des rappels cachés et personnalisés.

Toutes les actualités

Archive

✕
26 septembre 2018, 14:08
243

Immunotherapy of HIV passed the first phase of clinical trials

Preliminary results from phase I clinical trials demonstrated the safety and tolerability of cell therapy, including the introduction of artificially expanded T-cells with widely neutralizing antibodies (#bNAbs) into the blood of HIV-positive volunteers who had previously ...
25 septembre 2018, 14:04
257

American patients with hepatitis C will be available branded generics Gilead

On Monday, September 24, the American biopharmaceutical company Gilead Sciences Inc. said that it expects to launch in the US the production of a number of analogues for its own products. Among the applicants for the release are generic drugs for the treatment of hepatitis ...
24 septembre 2018, 13:52
216

The number of heterosexuals with HIV in Australia is growing - experts

According to the latest statistics published today by the Kirby Institute (University of New South Wales, Australia), the number of diagnoses of "#HIV infection" among Australian heterosexual men over the past five years has increased by 10%. The study showed that more than ...
18 septembre 2018, 13:49
183

Scientists: HIV should be considered a major risk factor for cardiovascular disease

People living with HIV are twice as likely to suffer from cardiovascular disease (#CVD), the results of a meta-analysis published in Circulation magazine show. According to researchers, over the past 20 years, the number of CVDs associated with HIV has tripled. Today this ...
17 septembre 2018, 13:42
146

EMA will consider an application for the registration of an antiviral drug dolutegravir / lamivudine

September 14 became known that the pharmaceutical company ViiV Healthcare, part of the GlaxoSmithKline structure, applied to the European Medicines Agency (#EMA) for the registration of a two-component antiretroviral dolutegravir / lamivudine intended for the treatment of ...
17 septembre 2018, 09:51
787

HIV-positive Norwegians may not get modern antiretroviral drugs

The Kingdom of Norway, which has maintained the status of the state with the world's highest human development index (HDI) for the last ten years and is the third largest on the planet by nominal GDP per capita, is on the verge of a crisis of underfunding the drug people ...
17 septembre 2018, 08:31
238

ViiV submits two-drug regimen for HIV in Europe

#ViiV Healthcare has submitted an application in Europe for a single-tablet, two-drug regimen of dolutegravir (#DTG) and lamivudine (#3TC) for the treatment of HIV-1 infection.
3 septembre 2018, 11:01
284

Early birth and weight loss: why Africa refuses dolutegravir?

Antiretroviral regimens (#ART) based on protease inhibitors or nucleoside reverse transcriptase inhibitors can cause early childbirth and low birth weight. This is reported by Aidsmap with reference to the Journal of Acquired Immune Deficiency Syndromes.
31 août 2018, 12:30
580

FDA approved two new drugs for HIV treatment

The US Food and Drug Administration (#FDA) has approved two new drugs for HIV treatment. This happened two months earlier than originally planned. The drugs are suitable for the treatment of adults with the most common strains of the virus and patients who have not received ...
30 août 2018, 09:52
549

Pharmacies in Finland began to sell rapid tests for HIV

In Finland, kits for testing HIV for blood drop, which can be used at home, were on sale. To get the result you need only wait 15 minutes.